Clinical Trial Update: Shigella Sonnei 53G Human Infection Study in Kenyan Adults [Phase 1]

View source ↗

Summary

Phase 1 human infection study of Shigella Sonnei 53G in Kenyan adults is currently recruiting, sponsored by the University of Oxford.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Shigellosis

Drugs mentioned

• Shigella Sonnei 53G challenge strain (Shigella sonnei 53G)

Snippet

Sponsor: University of Oxford | Conditions: Shigellosis | Phase 1 | Status: RECRUITING